These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 3322745)

  • 21. [Cardiac glycosides and calcium antagonists in the treatment of blood circulation insufficiency].
    Shushliapin OI; Sabodash VE; Kapustina LI; Shelest AN; Kononenko LG
    Vrach Delo; 1989 May; (5):28-31. PubMed ID: 2773424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapy of Vasospastic Angina.
    Harris JR; Hale GM; Dasari TW; Schwier NC
    J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):439-51. PubMed ID: 27081186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do vasospasms provoke ocular diseases?
    Gasser P; Flammer J; Guthauser U; Mahler F
    Angiology; 1990 Mar; 41(3):213-20. PubMed ID: 2310050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transient monocular blindness: Vascular causes and differential diagnoses].
    Bidot S; Biotti D
    J Fr Ophtalmol; 2018 May; 41(5):453-461. PubMed ID: 29776764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical application of Ca2(+)-antagonist for prevention and treatment of cerebral vasospasm].
    Kyoi K; Utsumi S
    Nihon Rinsho; 1989 Aug; 47(8):1831-6. PubMed ID: 2685399
    [No Abstract]   [Full Text] [Related]  

  • 26. Calcium antagonists in cerebral/peripheral vascular disorders. Current status.
    Tietze KJ; Schwartz ML; Vlasses PH
    Drugs; 1987 Jun; 33(6):531-8. PubMed ID: 3301300
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of nifedipine on ocular pulse amplitude in normal pressure glaucoma].
    Schmidt KG; von Rückmann A; Geyer O; Mittag TW
    Klin Monbl Augenheilkd; 1997 Jun; 210(6):355-9. PubMed ID: 9333660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of magnesium on visual field and peripheral vasospasm in glaucoma.
    Gaspar AZ; Gasser P; Flammer J
    Ophthalmologica; 1995; 209(1):11-3. PubMed ID: 7715920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular calcium, myosin light chain phosphorylation, and contractile force in experimental cerebral vasospasm.
    Bulter WE; Peterson JW; Zervas NT; Morgan KG
    Neurosurgery; 1996 Apr; 38(4):781-7; discussion 787-8. PubMed ID: 8692399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dihydropyridines and vascular diseases.
    Tamargo J; Delpón E
    Z Kardiol; 1991; 80 Suppl 7():106-11. PubMed ID: 1792815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral vasospasm.
    De Salles AA
    Arq Neuropsiquiatr; 1987 Sep; 45(3):329-38. PubMed ID: 3326553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Therapeutic value of treatment with calcium antagonists, hypervolemic hemodilution and induced arterial hypertension].
    Hansen D; Hannemann L; Specht M; Schaffartzik W
    Anaesthesist; 1995 Apr; 44(4):219-29. PubMed ID: 7785750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional coronary vasoconstriction after combined beta-adrenergic and calcium channel blockade in patients with coronary artery disease.
    Kern MJ; Petru MA; Ferry DR; Eilen SD; Barr WK; Porter CB; O'Rourke RA
    J Am Coll Cardiol; 1985 Jun; 5(6):1438-50. PubMed ID: 2860147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative study of nicardipine versus placebo in the prevention of cognitive deterioration in patients with transient ischemic attack].
    Moltó JM; Falip R; Martín R; Insa R; Pastor I; Matías-Guiu J
    Rev Neurol; 1995; 23(119):54-8. PubMed ID: 8548644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of physical exercise and nifedipine on ocular pulse amplitude.
    Schmidt KG; Mittag TW; Pavlovic S; Hessemer V
    Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234(8):527-32. PubMed ID: 8858360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical potential of lomerizine, a Ca2+ channel blocker as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damage.
    Hara H; Toriu N; Shimazawa M
    Cardiovasc Drug Rev; 2004; 22(3):199-214. PubMed ID: 15492768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of vasospasm due to subarachnoid hemorrhage with calcium entry blockers.
    Przuntek H; von Baumgarten F; Mertens HG
    Eur Neurol; 1986; 25 Suppl 1():86-92. PubMed ID: 3530777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative middle cerebral artery flow in normal and vasospastic arteries.
    Austin G; Gaskell R
    Neurol Res; 1992; 14(2 Suppl):192-6. PubMed ID: 1355887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current aspects of drug correction of impaired circulation in the ocular vessels].
    Kiseleva TN; Polunin GS; Lagutina IuM
    Vestn Oftalmol; 2007; 123(2):37-9. PubMed ID: 17650609
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.